DIVISLAB.BO

DIVI'S LABORATORIES LTD. · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$18.70B

PE Ratio

72.4

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$1.07B

Net Income (TTM)

$258.3M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

12.00%

Profit Margin

24.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$18.70B

Revenue TTM$1.07B

Shares Outstanding265.5M

Float127612275

Insider Ownership52.00%

Institutional Ownership29.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)12.00%

Rev Growth Est 1Y Forward0.16

EPS Growth (Quarterly YoY)-1.00%

EPS Growth Est Quarterly23.28

LT EPS Growth Estimates21.00%

Operations16 fields›

Revenue TTM$1.07B

Gross Margin TTM62.00%

Gross Margin (Quarterly)64.00%

Operating Margin TTM30.00%

Operating Margin (Quarterly)30.00%

Operating Expenses TTM$1.0M

Profit Margin TTM24.00%

Profit Margin (Quarterly)22.00%

Net Income TTM$258.3M

EPS TTM93.14

EPS (Quarterly)21.96

EBITDA Margin TTM33.00%

EBITDA TTM$350.4M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

FCF % of Revenue (Quarterly)2.00%

Efficiency1 fields›

ROA10.00%

Valuation7 fields›

P/E (TTM)72.4

P/E Forward0

EV/Revenues (TTM)16.79

Price To Book11.99

Price to Tangible Book11.99

Earnings Yield1.00%

Payout Ratio43.00%

Liquidity5 fields›

Current Ratio6.94

Total Assets$1.76B

Total Liabilities$764.5M

Shareholders Equity$1.56B

Interest Expense$1.0M

Yields3 fields›

Payout Ratio43.00%

Earnings Yield1.00%

Buyback Yield0.00%